Annual report pursuant to Section 13 and 15(d)

Investment (Details)

v3.21.4
Investment (Details) - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Feb. 28, 2021
Schedule of Equity Method Investments [Line Items]      
DepYmed preferred shares received in sale of intellectual property $ 316,724 $ 0  
DepYmed      
Schedule of Equity Method Investments [Line Items]      
Percentage of ownership held     15.00%
Carrying value of DepYmed common shares   224,537  
Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr 99,020 99,020  
DepYmed preferred shares received in sale of intellectual property (316,724)    
Total Investment 415,744 $ 323,557  
DepYmed | Intellectual property | Other income (expense)      
Schedule of Equity Method Investments [Line Items]      
DepYmed preferred shares received in sale of intellectual property $ 300,000